Mats Wahlstrom - 15 May 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 May 2026, 16:42:42 UTC
Prior SEC filing
15 May 2026
Next SEC filing
09 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mary Szela, Attorney-in-Fact

Key filing fact

Mats Wahlstrom filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 18 May 2026.

Key facts

  • This page summarizes Mats Wahlstrom's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 May 2026, 16:42.

Change

  • Previous filing in this sequence was filed on 15 May 2026.
  • Current net transaction value: +$151,800.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001459154 Primary reporting owner

Wahlstrom Mats

Relationship
Director
Address
6272 W. 91ST AVENUE, WESTMINSTER
Signature
/s/ Mary Szela, Attorney-in-Fact
Signature date
18 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Purchase

Transaction value
$151,800
Shares
+60,000
Change %
+69%
Price
$2.53
Shares after
147,555
Date
15 May 2026
Ownership
Direct
Footnotes
F1
TLSI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,444,447
Date
15 May 2026
Ownership
By Leonard Capital LLC
Footnotes
F2
TLSI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,370,028
Date
15 May 2026
Ownership
By HW Investment Partners, LLC
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Footnote F2

The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC.

Footnote F3

The Reporting Person is a managing member of HW Investment Partners, LLC ("HW Investment") and shares voting and investment discretion with respect to the shares held directly by HW Investment. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .